# Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/experience-with-early-sorafenib-treatment-with-mtor-inhibitors-in-hepatocellular/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Federica Invernizzi,Massimo Iavarone,Claudio Zavaglia,Stefano Mazza,U. Maggi,Lucia Cesarini,Barbara Antonelli,Aldo Airoldi,M.A. Manini,Angelo Sangiovanni,G. Rossi,Maria Francesca Donato,L Belli,Pietro Lampertico |
| Citations | 54 |
| DOI | 10.1097/tp.0000000000002955 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/2434/676461 |
| OpenAlex ID | https://openalex.org/W2973188007 |
| PMID | 31517781 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Stefano Mazza](https://scholariq.org/researchers/stefano-mazza/)

## Paper journal

- [Transplantation](https://scholariq.org/journals/transplantation/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.